Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Tarsus Pharmaceuticals, Inc.”

9 pharma patents match "Tarsus Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "Tarsus Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “Tarsus Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 12364685

    Isoxazoline parasiticide formulations

    Tarsus Pharmaceuticals, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  2. US 12257263

    Pharmaceutical compositions for demodex related blepharitis and eyelid crusting

    Tarsus Pharmaceuticals, Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  3. US 12213964

    Isoxazoline parasiticide formulations

    Tarsus Pharmaceuticals, Inc. · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  4. US 12171750

    Isoxazoline parasiticide formulations and methods for treating blepharitis

    Tarsus Pharmaceuticals, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  5. US 11752137

    Ophthalmic compositions for treating ocular Demodex using lotilaner formulations

    Tarsus Pharmaceuticals, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  6. US 11690826

    Methods for treating demodex blepharitis using lotilaner formulations

    Tarsus Pharmaceuticals, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  7. US 11690827

    Methods for treating ocular Demodex using lotilaner formulations

    Tarsus Pharmaceuticals, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  8. US 11197847

    Isoxazoline parasiticide formulations and methods for treating blepharitis

    Tarsus Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  9. US 10835517

    Methods for treating ocular demodex using isoxazoline parasiticide formulations

    Tarsus Pharmaceuticals, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted